DK534279A - 5-methylisoxazol-4-carboxylsyre-4-trifluomethyl)-anilid dets fremstilling og anvendelse samt mellemprodukter til brug ved fremsillingen - Google Patents
5-methylisoxazol-4-carboxylsyre-4-trifluomethyl)-anilid dets fremstilling og anvendelse samt mellemprodukter til brug ved fremsillingenInfo
- Publication number
- DK534279A DK534279A DK534279A DK534279A DK534279A DK 534279 A DK534279 A DK 534279A DK 534279 A DK534279 A DK 534279A DK 534279 A DK534279 A DK 534279A DK 534279 A DK534279 A DK 534279A
- Authority
- DK
- Denmark
- Prior art keywords
- trifluomethyl
- methylisoxazole
- anilide
- intermediates
- manufacturing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782854439 DE2854439A1 (de) | 1978-12-16 | 1978-12-16 | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
DE2854439 | 1978-12-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK534279A true DK534279A (da) | 1980-06-17 |
DK149886B DK149886B (da) | 1986-10-20 |
DK149886C DK149886C (da) | 1987-04-21 |
Family
ID=6057414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK534279A DK149886C (da) | 1978-12-16 | 1979-12-14 | Analogifremgangsmaade til fremstilling af 5-methylisoxazol-4-carboxylsyre-(4-trifluormethyl)-anilid |
Country Status (25)
Country | Link |
---|---|
US (2) | US4284786A (da) |
EP (1) | EP0013376B1 (da) |
JP (1) | JPS5583767A (da) |
AR (2) | AR222680A1 (da) |
AT (1) | ATE1067T1 (da) |
AU (1) | AU529341B2 (da) |
BG (1) | BG60764B2 (da) |
CA (1) | CA1129867A (da) |
DE (2) | DE2854439A1 (da) |
DK (1) | DK149886C (da) |
EG (1) | EG13926A (da) |
ES (2) | ES486750A1 (da) |
FI (1) | FI64154C (da) |
GR (1) | GR72731B (da) |
HU (1) | HU178015B (da) |
IE (1) | IE49126B1 (da) |
IL (1) | IL58951A (da) |
LU (1) | LU90466I2 (da) |
MX (2) | MX6174E (da) |
NL (1) | NL990037I1 (da) |
NO (1) | NO148925C (da) |
NZ (1) | NZ192400A (da) |
PH (1) | PH16627A (da) |
PT (1) | PT70596A (da) |
ZA (1) | ZA796793B (da) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3247454A1 (de) * | 1982-12-22 | 1984-06-28 | Laboratorios Bago S.A., Buenos Aires | Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
FR2538806B1 (fr) * | 1982-12-30 | 1986-02-21 | Bago Sa Labor | Composes phenyl-3 methyl isoxazole-5 carboxy-4 anilides substitues, actifs therapeutiquement contre l'inflammation et la douleur |
US5268382A (en) * | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
US4935434A (en) * | 1988-01-26 | 1990-06-19 | Bristol-Myers Company | Antiarthritic isoxazole-4-carboxamides |
FR2662692B1 (fr) * | 1990-05-30 | 1995-04-28 | Novapharme | Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique. |
US5258397A (en) * | 1988-11-30 | 1993-11-02 | Novapharme | 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions |
US5583150A (en) * | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
DD297328A5 (de) * | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen |
US5001124A (en) * | 1990-02-02 | 1991-03-19 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
US5108999A (en) * | 1990-02-02 | 1992-04-28 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
DK0527736T3 (da) * | 1990-05-18 | 1997-10-20 | Hoechst Ag | Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler. |
DE4127737A1 (de) | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
US6133301A (en) * | 1991-08-22 | 2000-10-17 | Aventis Pharma Deutschland Gmbh | Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
ATE174218T1 (de) * | 1993-01-08 | 1998-12-15 | Hoechst Ag | Verwendung von leflunomid zur hemmung von interleukin 1 beta |
DK0607777T3 (da) * | 1993-01-08 | 1999-08-16 | Hoechst Ag | Anvendelse af leflunomid til inhibering af interleukin 8 |
ES2124801T3 (es) * | 1993-01-08 | 1999-02-16 | Hoechst Ag | Empleo de leflunomida para la inhibicion del factor de necrosis de tumores alfa. |
DE59407412D1 (de) * | 1993-01-08 | 1999-01-21 | Hoechst Ag | Verwendung von Leflunomid zur Hemmung von Interleukin 1 alpha |
TW314467B (da) * | 1993-03-31 | 1997-09-01 | Hoechst Ag | |
DE4323636A1 (de) * | 1993-07-15 | 1995-01-19 | Hoechst Ag | Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung |
LT3589B (en) | 1993-11-30 | 1995-12-27 | Hoechst Ag | Using of known combination for treatment of rejection reaction by transplantation of organs |
US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
US6335356B1 (en) | 1994-01-07 | 2002-01-01 | Sugen, Inc. | Method of treating a patient by parenteral administration of a lipophilic compound |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
US5519042A (en) * | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
US5624946A (en) * | 1994-07-05 | 1997-04-29 | Williams; James | Use of leflunomide to control and reverse chronic allograft rejection |
AU695907B2 (en) * | 1994-10-17 | 1998-08-27 | Hoechst Pharmaceuticals & Chemicals K.K. | Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases |
US5721277A (en) * | 1995-04-21 | 1998-02-24 | Sugen, Inc. | Compounds and methods for inhibiting hyper-proliferative cell growth |
US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
DE19539638A1 (de) * | 1995-10-25 | 1997-04-30 | Hoechst Ag | Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen |
DE19702988A1 (de) * | 1997-01-28 | 1998-07-30 | Hoechst Ag | Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika |
US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
DK0903345T3 (da) * | 1997-08-08 | 2000-10-23 | Aventis Pharma Gmbh | Krystalform af N-(4-trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid |
US7691890B2 (en) | 1998-03-11 | 2010-04-06 | James W. Williams | Anti-viral uses of leflunomide products |
US20050255071A1 (en) * | 1998-12-10 | 2005-11-17 | Aventis Pharma Deutschland Gmbh | Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors |
DE19908527C2 (de) * | 1999-02-26 | 2001-08-30 | Aventis Pharma Gmbh | Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid |
US6566395B1 (en) | 1999-05-25 | 2003-05-20 | Biomedicines, Inc. | Methods of treating proliferative disorders |
DE19960443C2 (de) * | 1999-12-15 | 2002-05-08 | Aventis Pharma Gmbh | Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen |
AU779931B2 (en) * | 1999-12-16 | 2005-02-17 | Teva Pharmaceutical Industries Ltd. | Novel processes for making- and a new crystalline form of- leflunomide |
EP1473035A1 (en) * | 2000-02-15 | 2004-11-03 | Teva Pharmaceutical Industries Ltd. | Leflunomide of high purity |
KR20020072312A (ko) * | 2000-02-15 | 2002-09-14 | 테바 파마슈티컬 인더스트리즈 리미티드 | 레플루노미드를 합성하는 방법 |
AU2001284891A1 (en) * | 2000-08-14 | 2002-02-25 | Teva Pharmaceutical Industries Ltd. | Micronized leflunomide |
GB0123571D0 (en) | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
WO2002080897A1 (en) | 2001-04-05 | 2002-10-17 | Aventis Pharmaceuticals Inc. | Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
WO2003042193A1 (en) * | 2001-11-09 | 2003-05-22 | Geneva Pharmaceuticals, Inc. | Process for preparing 5-methylisoxazole-4-carboxylic-(4'-trifluoromethyl)-anilide |
US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
CA2571710A1 (en) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
US20060024376A1 (en) * | 2004-07-30 | 2006-02-02 | The University Of Chicago | Methods and compositions for reducing toxicity associated with leflunomide treatment |
WO2007026737A1 (ja) * | 2005-08-31 | 2007-03-08 | Kowa Co., Ltd. | 関節リウマチの予防及び/又は治療法 |
WO2008093246A2 (en) * | 2007-02-02 | 2008-08-07 | Vegenics Limited | Vegf receptor antagonist for treating organ transplant alloimmunity and arteriosclerosis |
CN101817797B (zh) * | 2009-02-26 | 2013-04-10 | 江苏亚邦爱普森药业有限公司 | 高纯度3-甲基-n-[4-(三氟甲基)苯基]-4-异噁唑甲酰胺的合成方法 |
US9205577B2 (en) * | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
US11202853B2 (en) * | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
JOP20190207A1 (ar) | 2017-03-14 | 2019-09-10 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على بونيسيمود |
JP2021519334A (ja) | 2018-03-26 | 2021-08-10 | クリア クリーク バイオ, インコーポレイテッド | ジヒドロオロト酸デヒドロゲナーゼを阻害するための組成物および方法 |
IL295976A (en) | 2020-03-06 | 2022-10-01 | Actelion Pharmaceuticals Ltd | Methods to slow the loss of brain volume |
CA3221343A1 (en) | 2021-10-11 | 2023-04-20 | Allitia DIBERNARDO | Methods of treating multiple sclerosis |
WO2023152290A1 (en) | 2022-02-11 | 2023-08-17 | Actelion Pharmaceuticals Ltd | Methods of slowing an increase in brain ventricular volume |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4087534A (en) * | 1974-05-22 | 1978-05-02 | David Ovadia | N-haloalkylmio urazole pesticides |
NL178596C (nl) * | 1975-06-05 | 1986-04-16 | Hoechst Ag | Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden. |
DE2524959C2 (de) * | 1975-06-05 | 1983-02-10 | Hoechst Ag, 6000 Frankfurt | 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel |
DE2654797A1 (de) * | 1976-12-03 | 1978-06-08 | Hoechst Ag | Verfahren zur herstellung von isoxazolderivaten |
-
1978
- 1978-12-16 DE DE19782854439 patent/DE2854439A1/de not_active Withdrawn
-
1979
- 1979-12-11 ES ES486750A patent/ES486750A1/es not_active Expired
- 1979-12-11 ES ES486758A patent/ES486758A1/es not_active Expired
- 1979-12-12 EG EG748/79A patent/EG13926A/xx active
- 1979-12-13 MX MX798546U patent/MX6174E/es unknown
- 1979-12-13 US US06/103,551 patent/US4284786A/en not_active Expired - Lifetime
- 1979-12-13 AT AT79105142T patent/ATE1067T1/de active
- 1979-12-13 FI FI793899A patent/FI64154C/fi not_active IP Right Cessation
- 1979-12-13 EP EP79105142A patent/EP0013376B1/de not_active Expired
- 1979-12-13 DE DE7979105142T patent/DE2962929D1/de not_active Expired
- 1979-12-14 PT PT70596A patent/PT70596A/pt active IP Right Revival
- 1979-12-14 GR GR60761A patent/GR72731B/el unknown
- 1979-12-14 NO NO794094A patent/NO148925C/no unknown
- 1979-12-14 AU AU53853/79A patent/AU529341B2/en not_active Expired
- 1979-12-14 IE IE2426/79A patent/IE49126B1/en active Protection Beyond IP Right Term
- 1979-12-14 AR AR279310A patent/AR222680A1/es active
- 1979-12-14 NZ NZ192400A patent/NZ192400A/xx unknown
- 1979-12-14 CA CA342,109A patent/CA1129867A/en not_active Expired
- 1979-12-14 JP JP16170079A patent/JPS5583767A/ja active Granted
- 1979-12-14 HU HU79HO2201A patent/HU178015B/hu unknown
- 1979-12-14 IL IL58951A patent/IL58951A/xx unknown
- 1979-12-14 ZA ZA00796793A patent/ZA796793B/xx unknown
- 1979-12-14 DK DK534279A patent/DK149886C/da active
- 1979-12-14 PH PH23418A patent/PH16627A/en unknown
-
1981
- 1981-03-03 US US06/239,986 patent/US4351841A/en not_active Expired - Lifetime
- 1981-05-19 AR AR285378A patent/AR226894A1/es active
-
1984
- 1984-03-12 MX MX8403A patent/MX8403A/es unknown
-
1994
- 1994-02-23 BG BG98534A patent/BG60764B2/bg unknown
-
1999
- 1999-10-27 LU LU90466C patent/LU90466I2/fr unknown
- 1999-10-29 NL NL990037C patent/NL990037I1/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK534279A (da) | 5-methylisoxazol-4-carboxylsyre-4-trifluomethyl)-anilid dets fremstilling og anvendelse samt mellemprodukter til brug ved fremsillingen | |
DK326280A (da) | Laminatmateriale samt fremgangsmaade til dets fremstilling | |
DK69580A (da) | Forstaerket slagfast harpkis-materiale og fremgangsmaade til dets fremstilling | |
NO156125C (no) | Silisiumdioksyd-basert syntetisk material og fremgangsmaate for dets fremstilling. | |
DK160943C (da) | Analogifremgangsmaade til fremstilling af acyloxyalkyl-6-(alfa, alfa-disubstituerede acetamido)penicillanater samt et udgangsmateriale til fremstilling heraf | |
IT1111011B (it) | Peralogenoalchilvinilciclopropancar bossilati ad azione insetticida,e intermedi per gli stessi | |
DK355679A (da) | Naphthyridinderivater samt mellemprodukter og fremgangsmaader til fremstilling deraf | |
NO801629L (no) | Termisk isolerende, bituminoest vanntett platemateriale samt fremgangsmaate for dets paafoering | |
DE2966051D1 (en) | Piezoelectric resonator | |
NO803859L (no) | Poroest krystallinsk material, fremgangsmaate for dets fremstilling og anvendelse av materialet | |
BR8201025A (pt) | Aparelho sensor de gas,processo para fabricar o mesmo material sensor de gas,processo para fabricar um monitor de gas | |
DK479879A (da) | Fodtoej samt fremgangsmaade til dets fremstilling | |
BR7907901A (pt) | Processo para a preparacao de 2,3,5-tricloropiridina,2,4,4-tricloro-4-formil-butironitrila e processo para sua preparacao | |
DK98182A (da) | Fungicidt praeparat,fremgangsmaade til dets fremstilling samt anvendelse deraf | |
NL190593C (nl) | Piëzo-elektrische resonator. | |
DK359280A (da) | 4-fluor-3-phenoxy-benzaldehyd-acetaler og fremgangsmaade til fremstilling heraf samt mellemprodukter til brug herved og fremgangsmaade til disses fremstilling | |
DK364581A (da) | Staal-haardcarbid-materiale dets fremstilling og anvendelse | |
BR8106017A (pt) | Meio magnetico e processo de sua fabricacao | |
DK49281A (da) | Skaalformet engangsprodukt samt fremgangsmaade til dets fremstilling | |
NO149887C (no) | Plateformet isolasjonselement og fremgangsmaate til dets fremstilling. | |
DK276979A (da) | Stabiliseret fungicid og fremgangsmaade til dets fremstilling | |
IT1162603B (it) | Impianto per il rivestimento di porzioni glassate con un prodotto granulato e procedimento per il suo funzionamento | |
DK467780A (da) | Fremgangsmaade til fremstilling af 24,24-difluor25-hydrochlecalciferol og mellemprodukter til brug ved fremgangsmaaden | |
DK266279A (da) | Smoeremiddel og smoeremiddel-addition samt fremgangsmaader til dets fremstilling og anvendelse | |
DK326085D0 (da) | 4-amino-2-phenylquinoliner, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter |